Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-162-7
CAS number: 78-96-6
In accordance with column 2 of REACH Annex X, as the substance is not mutagenic and as no hyperplasia and/or pre-neoplastic lesions were observed in the repeated dose studies, a carcinogenicity study is not necessary.
No information available.
Based on the negative results in the in
vitro and in vivo genotoxicity studies, and the absence of hyperplasia
and/or pre-neoplastic lesions in the available repeated dose studies,
MIPA is considered to be non-carcinogenic. As
a result the substance is not considered to be classified for
carcinogenicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
За да гарантираме, че се възползвате максимално от функциите на нашия уебсайт, сме въвели „бисквитки“.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again